Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

4.73
-0.0500-1.05%
Pre-market: 4.72-0.0100-0.21%09:00 EDT
Volume:39.09K
Turnover:184.10K
Market Cap:50.48M
PE:-0.23
High:4.88
Open:4.88
Low:4.53
Close:4.78
Loading ...
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 03, 2023

Major Issues Report

8-K - Current report
Jan 17, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Major Issues Report

8-K - Current report
Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 16, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Major Issues Report

8-K - Current report
Aug 11, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2022

Major Issues Report

8-K - Current report
Jul 22, 2022

Major Issues Report

8-K - Current report